Pharmaceutical company Sanofi intends to invest at least $20 billion in the United States through 2030, the company says in a Wednesday announcement. The company plans to grow its investments in science and expand domestic manufacturing in the US over the next several years.

“Sanofi’s 13,000 US-based employees are pioneering the research and development of first- and best-in-class medicines across numerous therapeutic areas. Our expected investments in the US will be substantial and will help ensure the production of key medicines in the US.”

Sanofi is preparing for the potential launch of numerous new first- or best-in-class medicines across many indications in the coming years, aiming to improve the health of countless Americans. The pharmecutical powerhouse expects the investments to unlock plenty of jobs for Americans in select communities, as well as enhance its US supply chain.

Also Read: Ripple Meets with UAE Officials to at Dubai Fintech Summit

Furthermore, Sanofi also plans to expand its US manufacturing capacity along with the US investment. The comapny will accomplish this through direct investments in Sanofi sites, as well as through partnerships with other domestic manufacturers, to help ensure the production of medicines in the US.